66 related articles for article (PubMed ID: 3730177)
1. [Determination of indapamide in plasma by HPLC].
Gaetani E; Laureri CF; Vitto M; Borghi L; Elia GF; Novarini A
Boll Chim Farm; 1986 Jan; 125(1):35-7. PubMed ID: 3730177
[No Abstract] [Full Text] [Related]
2. High-performance liquid chromatographic analysis of indapamide (RHC 2555) in urine, plasma and blood.
Choi RL; Rosenberg M; Grebow PE; Huntley TE
J Chromatogr; 1982 Jun; 230(1):181-7. PubMed ID: 7107760
[No Abstract] [Full Text] [Related]
3. Liquid chromatography-tandem mass spectrometry validated method for the estimation of indapamide in human whole blood.
Jain DS; Subbaiah G; Sanyal M; Pande UC; Shrivastav P
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Apr; 834(1-2):149-54. PubMed ID: 16531130
[TBL] [Abstract][Full Text] [Related]
4. Indapamide binding to alpha 1-acid glycoprotein: consequences on its blood distribution and plasma binding in disease states.
Urien S; Guez D; Thénot A; Tillement JP
Prog Clin Biol Res; 1989; 300():449-52. PubMed ID: 2780643
[No Abstract] [Full Text] [Related]
5. Semiautomated assay for indapamide in biological fluids.
Grebow PE; Treitman JA; Yeung AK; Johnston MM
J Pharm Sci; 1981 Mar; 70(3):306-8. PubMed ID: 7264897
[TBL] [Abstract][Full Text] [Related]
6. Determination of lauroyl-indapamide in rat whole blood by high-performance liquid chromatography.
Suo X; Deng Y; Hao A
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May; 819(1):191-6. PubMed ID: 15797539
[TBL] [Abstract][Full Text] [Related]
7. Effects of competitive red blood cell binding and reduced hematocrit on the blood and plasma levels of [14C]Indapamide in the rat.
Lettieri JT; Portelli ST
J Pharmacol Exp Ther; 1983 Feb; 224(2):269-72. PubMed ID: 6822954
[TBL] [Abstract][Full Text] [Related]
8. Simple, sensitive and rapid LC-MS method for the quantitation of indapamide in human plasma--application to pharmacokinetic studies.
Chen WD; Liang Y; Zhang H; Li H; Xiong Y; Wang GJ; Xie L
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Sep; 842(1):58-63. PubMed ID: 16843739
[TBL] [Abstract][Full Text] [Related]
9. A selective HPLC method for the determination of indapamide in human whole blood: application to a bioequivalence study in Chinese volunteers.
Hang TJ; Zhao W; Liu J; Song M; Xie Y; Zhang Z; Shen J; Zhang Y
J Pharm Biomed Anal; 2006 Jan; 40(1):202-5. PubMed ID: 16111851
[TBL] [Abstract][Full Text] [Related]
10. Determination of indapamide in human serum using 96-well solid-phase extraction and high-performance liquid chromatography-tandem mass spectrometry (LC-MS/MS).
Morihisa H; Fukata F; Muro H; Nishimura K; Makino T
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(1):126-30. PubMed ID: 18554994
[TBL] [Abstract][Full Text] [Related]
11. A sensitive LC-ESI-MS method for the determination of indapamide in human plasma: method and clinical applications.
Ding L; Yang L; Liu F; Ju W; Xiong N
J Pharm Biomed Anal; 2006 Sep; 42(2):213-7. PubMed ID: 16781839
[TBL] [Abstract][Full Text] [Related]
12. Liquid chromatography-electrospray tandem mass spectrometry method for determination of indapamide in serum for single/multiple dose bioequivalence studies of sustained release formulations.
Albu F; Georgiţă C; David V; Medvedovici A
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 816(1-2):35-40. PubMed ID: 15664331
[TBL] [Abstract][Full Text] [Related]
13. Determination of furosemide in plasma and urine using monolithic silica rod liquid chromatography.
Wenk M; Haegeli L; Brunner H; Krähenbühl S
J Pharm Biomed Anal; 2006 Jun; 41(4):1367-70. PubMed ID: 16569489
[TBL] [Abstract][Full Text] [Related]
14. Serum binding of indapamide in health and disease: primary role of alpha 1-acid glycoprotein.
Urien S; Morin D; d'Athis P; Coulomb B; Tillement JP
J Clin Pharmacol; 1988 May; 28(5):458-62. PubMed ID: 3392244
[TBL] [Abstract][Full Text] [Related]
15. Rapid and sensitive determination of indapamide in human blood by liquid chromatography with electrospray ionization mass spectrometric detection: application to a bioequivalence study.
Tang J; Li J; Sun J; Yin J; He Z
Pharmazie; 2005 Nov; 60(11):819-22. PubMed ID: 16320942
[TBL] [Abstract][Full Text] [Related]
16. An overview of the pharmacology and clinical efficacy of indapamide sustained release.
Sassard J; Bataillard A; McIntyre H
Fundam Clin Pharmacol; 2005 Dec; 19(6):637-45. PubMed ID: 16313275
[TBL] [Abstract][Full Text] [Related]
17. Sample preparation and RPHPLC determination of diuretics in human body fluids.
Zendelovska D; Stafilov T
Acta Pharm; 2006 Jun; 56(2):115-42. PubMed ID: 16613721
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of hypertension with indapamide 1.5 mg sustained-release form: synthesis of results].
Guez D; Mallion JM; Degaute JP; Malini PL; Baldwin R; Rodriguez-Pujol D; de Cordoüe A; Barrandon S; Chastang C; Safar M
Arch Mal Coeur Vaiss; 1996 Sep; 89 Spec No 4():17-25. PubMed ID: 8952810
[TBL] [Abstract][Full Text] [Related]
19. [Indapamide--a substitute diuretic for hypertensives with hyperglycemia and/or dyslipidemia].
Sharabi Y; Grossman E; Nussinovitch N; Katz A; Rachima-Moaz C; Rosenthal T
Harefuah; 1996 Oct; 131(7-8):233-6, 295. PubMed ID: 8940516
[TBL] [Abstract][Full Text] [Related]
20. Determination of diuretics in human urine by hollow fiber-based liquid-liquid-liquid microextraction coupled to high performance liquid chromatography.
Zhang Z; Wang D; Zhang L; Du M; Chen G
Analyst; 2008 Sep; 133(9):1187-94. PubMed ID: 18709193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
